Protein kinase C signalling pathway is involved in the regulation of vascular endothelial growth factor expression in human bladder transitional carcinoma cells

被引:20
作者
Chabannes, E
Fauconnet, S
Bernardini, S
Wallerand, H
Adessi, GL
Bittard, H
机构
[1] Hop St Jacques, Urol Serv, F-25000 Besancon, France
[2] IETG, F-25000 Besancon, France
关键词
bladder cancer; RT4; cells; vascular endothelial growth factor; protein kinase C; phorbol myristate acetate;
D O I
10.1016/S0898-6568(01)00184-X
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Vascular endothelial growth factor (VEGF) is a potent angiogenic factor associated with the growth and metastasis of various cancers and plays a prominent role in vesical angiogenesis regulation. In this study, we investigated the effect of the phorbol 12-myristate 13-acetate (PMA) on the expression of VEGF in human bladder transitional carcinoma cells (RT4). RT4 cells expressed three VEGF isoforms (VEGF(189), VEGF(165), VEGF(121)). PMA increased VEGF mRNA expression time-dependently with a peak at 4 h. PMA increased the half-life of VEGF mRNA. The amount of VEGF protein in conditioned media was increased by PMA in a dose-dependent manner with a maximal effect at 10(-7) M. Staurosporine and calphostin C (PKC inhibitors) decreased PMA-induced VEGF mRNA expression as opposed to protein kinase A or cyclic nucleotide-dependent protein kinase inhibitors. Thus, in RT4 cells, VEGF expression is up-regulated by PMA via the PKC signalling pathway and according to a posttranscriptional mechanism. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:585 / 591
页数:7
相关论文
共 29 条
[1]  
BROWN LF, 1993, AM J PATHOL, V143, P1255
[2]   Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells [J].
Chin, K ;
Kurashima, Y ;
Ogura, T ;
Tajiri, H ;
Yoshida, S ;
Esumi, H .
ONCOGENE, 1997, 15 (04) :437-442
[3]  
CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317
[4]   Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates - Reply [J].
Crew, JP ;
O'Brien, T ;
Bicknell, R ;
Fuggle, S ;
Cranston, D ;
Harris, AL .
JOURNAL OF UROLOGY, 1999, 161 (03) :804-804
[5]  
Crew JP, 1997, CANCER RES, V57, P5281
[6]  
Dean N, 1996, CANCER RES, V56, P3499
[7]   PITUITARY FOLLICULAR CELLS SECRETE A NOVEL HEPARIN-BINDING GROWTH-FACTOR SPECIFIC FOR VASCULAR ENDOTHELIAL-CELLS [J].
FERRARA, N ;
HENZEL, WJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :851-858
[8]   Vascular endothelial growth factor [J].
Ferrara, N .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (14) :2413-2422
[9]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[10]   ISOLATION AND CHARACTERIZATION OF A VASCULAR ENDOTHELIAL-CELL MITOGEN PRODUCED BY PITUITARY-DERIVED FOLLICULO STELLATE CELLS [J].
GOSPODAROWICZ, D ;
ABRAHAM, JA ;
SCHILLING, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (19) :7311-7315